These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6368941)

  • 21. Surface antigen on Ehrlich ascites tumor cells.
    Pessina A; Brambilla P; Mocarelli P
    Biomedicine; 1980; 33(4):105-9. PubMed ID: 7000194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of tumor-enhancing IgG2 on macrophage function.
    Cruse JM; Lewis R; Dilioglou S
    Exp Mol Pathol; 2004 Aug; 77(1):43-8. PubMed ID: 15215049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of macrophage subpopulations responsive to activation by endotoxin and lymphokines.
    Lee KC; Wong M; McIntyre D
    J Immunol; 1981 Jun; 126(6):2474-9. PubMed ID: 6971902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
    Da Silva SL; Chaar Jda S; Yano T
    Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma.
    Zhang B; Wang J; Gao J; Guo Y; Chen X; Wang B; Gao J; Rao Z; Chen Z
    J Cell Biochem; 2009 May; 107(1):134-43. PubMed ID: 19241443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination routes that fail to elicit protective immunity against Schistosoma mansoni induce the production of TGF-beta, which down-regulates macrophage antiparasitic activity.
    Williams ME; Caspar P; Oswald I; Sharma HK; Pankewycz O; Sher A; James SL
    J Immunol; 1995 May; 154(9):4693-700. PubMed ID: 7722322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of macrophage-mediated cytotoxicity: production of a soluble cytotoxic factor.
    Drysdale BE; Zacharchuk CM; Shin HS
    J Immunol; 1983 Nov; 131(5):2362-7. PubMed ID: 6415164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanoma inhibits macrophage activation by suppressing toll-like receptor 4 signaling.
    Clarke JH; Cha JY; Walsh MD; Gamboni-Robertson F; Banerjee A; Reznikov LL; Dinarello CA; Harken AH; McCarter MD
    J Am Coll Surg; 2005 Sep; 201(3):418-25. PubMed ID: 16125076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of macrophage suppression and cytotoxicity by interferon role of Ia-bearing macrophages.
    Boraschi D; Niederhuber JE
    J Immunol; 1982 Nov; 129(5):1854-8. PubMed ID: 6956630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemokinetic responses of murine macrophages to culture fluids from syngeneic neoplastic cells.
    Snodgrass MJ; Kaplan AM
    J Reticuloendothel Soc; 1978 Dec; 24(6):667-71. PubMed ID: 752074
    [No Abstract]   [Full Text] [Related]  

  • 31. A study of the differential respiratory burst activity elicited by promastigotes and amastigotes of Leishmania donovani in murine resident peritoneal macrophages.
    Channon JY; Roberts MB; Blackwell JM
    Immunology; 1984 Oct; 53(2):345-55. PubMed ID: 6490087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of macrophage phagocytosis of syngeneic erythrocytes by T-cell subsets from NZB mice: differential effects of T cells from young and old mice.
    Nakamura K; Yoshii A; Akahoshi T; Kashiwazaki S; Kawakami M
    Immunology; 1982 Jul; 46(3):561-73. PubMed ID: 6980184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing the detection of cell surface antigens on elicited or activated mouse peritoneal macrophages.
    Hendrzak JA; Wallace PK; Morahan PS
    Cytometry; 1994 Dec; 17(4):349-56. PubMed ID: 7875043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies directed against mouse macrophages in different stages of activation for tumor cytotoxicity.
    Taniyama T; Tokunaga T
    J Immunol; 1983 Aug; 131(2):1032-7. PubMed ID: 6863926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N; Schneider M
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell priming against vesicular stomatitis virus analyzed in situ: red pulp macrophages, but neither marginal metallophilic nor marginal zone macrophages, are required for priming CD4+ and CD8+ T cells.
    Ciavarra RP; Buhrer K; Van Rooijen N; Tedeschi B
    J Immunol; 1997 Feb; 158(4):1749-55. PubMed ID: 9029112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneous secretory response of phagocytes from different anatomical districts to the dimorphic fungus Candida albicans.
    Blasi E; Puliti M; Pitzurra L; Bartoli A; Bistoni F
    Cell Immunol; 1994 Jan; 153(1):239-47. PubMed ID: 8287490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2.
    Milas L; Hersh EM; Hunter N
    Cancer Res; 1981 Jun; 41(6):2378-85. PubMed ID: 7237436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity.
    Adams DO; Johnson WJ; Marino PA
    Fed Proc; 1982 Apr; 41(6):2212-21. PubMed ID: 6804274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Separation of soluble amoebicidal and tumoricidal activity of activated macrophages.
    Fischer-Stenger K; Cabral GA; Marciano-Cabral F
    J Protozool; 1992; 39(1):235-41. PubMed ID: 1560419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.